Negative regulation of oxidoreductase activity

pathway activity — cross-omics
GO:0051354Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of oxidoreductase activity pathway is significantly associated with the RNA expression of multiple genes, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SPOCK2, GZMK, and LY9, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of oxidoreductase activity activity versus SPOCK2 in CCRCC (Pearson r = 0.23).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCSPOCK2 →+0.530+0.165<.001<.00135
HNSCGZMK →+0.812+0.164.003.00635
LSCCLY9 →+0.492+0.115.008.00135
LSCCAPOL3 →+0.476+0.095.002.00135
LSCCCD27 →+0.571+0.125.002.00635
BRCAGZMA →+0.992+0.128.003.00635
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0051354 vs SPOCK2 — CCRCC

Per-sample scatter of Negative regulation of oxidoreductase activity activity vs SPOCK2 in CCRCC.

Explore this scatter interactively →

Exploration